144 related articles for article (PubMed ID: 28494532)
1. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study.
Wang SH; Chi CC; Zhao ZH; Tung TH
Cancer Res Treat; 2018 Apr; 50(2):428-435. PubMed ID: 28494532
[TBL] [Abstract][Full Text] [Related]
2. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
[TBL] [Abstract][Full Text] [Related]
3. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
[TBL] [Abstract][Full Text] [Related]
5. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study.
Song F; Qureshi AA; Giovannucci EL; Fuchs CS; Chen WY; Stampfer MJ; Han J
PLoS Med; 2013; 10(4):e1001433. PubMed ID: 23630459
[TBL] [Abstract][Full Text] [Related]
6. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan.
Wang CC; Tang CH; Wang CY; Huang SY; Sue YM
Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242
[TBL] [Abstract][Full Text] [Related]
7. The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population.
Graells J
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):142-7. PubMed ID: 15009290
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
Troyanova P; Danon S; Ivanova T
Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
[TBL] [Abstract][Full Text] [Related]
9. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
Brewster AM; Alberg AJ; Strickland PT; Hoffman SC; Helzlsouer K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study.
Rosenberg CA; Khandekar J; Greenland P; Rodabough RJ; McTiernan A
Cancer; 2006 Feb; 106(3):654-63. PubMed ID: 16365851
[TBL] [Abstract][Full Text] [Related]
11. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
12. The development of non-melanocytic skin cancers in people with a history of skin cancer.
Czarnecki D; Mar A; Staples M; Giles G; Meehan C
Dermatology; 1994; 189(4):364-7. PubMed ID: 7873821
[TBL] [Abstract][Full Text] [Related]
13. Risk of skin cancer in patients with pterygium: a nationwide population-based cohort study in Taiwan.
Yu HC; Lin CL; Chen ZT; Hu FR; Sung FC; Wang IJ
Ocul Surf; 2014 Jan; 12(1):69-76. PubMed ID: 24439048
[TBL] [Abstract][Full Text] [Related]
14. Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study.
Ong EL; Goldacre R; Hoang U; Sinclair R; Goldacre M
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):490-8. PubMed ID: 24609853
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
[TBL] [Abstract][Full Text] [Related]
17. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
18. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
19. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
20. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
Silverberg JI; Ratner D
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
